Skip to main content

Glaucoma Surgery Market is Increasing at a Supreme CAGR of 7.9% During Forecast to 2023


Glaucoma surgery market research report, by target (trabecular meshwork, suprachoroidal space and others), by type of surgery (angle closure glaucoma surgery, aqueous shunt surgery, laser surgery and other), by end user (hospital, ambulatory surgery centers and other)- forecast till 2023
Market Highlights:
Glaucoma refers to a particular disease that affects the eyesight of a person and can even cause blindness. It is a highly dangerous disease and usually considered as a chronic illness. This disease is mostly found in elderly people and is a result of aging. Other causes of glaucoma can be diabetes or deficiency of certain vitamins in the body. The number of glaucoma patients has risen sharply in recent times across the world and good surgeons are the immediate need for catering to such patients.
The global Glaucoma Surgery Market Growth was analyzed by Market Research Future (MRFR) and it was projected that a healthy CAGR of 7.9% will be attained by the market over the forecast period of 2018 to 2023. The valuation of the glaucoma surgery market was further stated to surpass its previous valuation by the end of the forecast period.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/1342

Increasing inclination towards permanent and faster cure through surgery over long-term use of medication is one of the major drivers of the global glaucoma surgery market. In addition, rise in prevalence of causative disorders such as diabetes and ocular hypertension are inducing need for surgical treatments, leading to the expansion of the global glaucoma surgery market.
However, lack of awareness, preference of non-invasive treatments and high cost associated with the treatment are likely to create hindrance in the growth of the global glaucoma surgery market during the forecast period.

Competitive Landscape:
·         Bausch & Lomb
·         Pfizer
·         Santen
·         Allergan
·         Merck & Co
·         Abbott
·         Ellex Medical Lasers
·         Lumenis
·         Novartis AG
·         Akor
·         Pharmaceuticals

Market Segmentation:
·         The global glaucoma surgery market has been segmented in terms of type of surgery, end-user, and target.
·         By target, the market divides into suprachoroidal space, trabecular meshwork, and others.
·         By type of surgery, the market segments into laser surgery, angle closure glaucoma surgery, aqueous shunt surgery, and other.
·         By end user, the market comprises into hospital, ambulatory surgery centers and other.

Regional Analysis:
The global Glaucoma Surgery Market Size is geographically distributed across the following key regions: Asia Pacific, North America, Europe, and the Middle East & Africa.
The global Glaucoma Surgery Industry is spearheaded by North America with the highest percentage of shares. This is due to the massive population herein that is suffering from diseases like diabetes and other critical eye diseases. The rising level of healthcare expenditure and enhanced infrastructure also has an influencing impact on the growth of the regional market.
Europe stands out as the second largest glaucoma surgery regional market Overview followed by Asia Pacific. In Asia Pacific, the presence of a huge population base and fast paced development in healthcare industry has helped attract a number of companies to develop there market in Asia Pacific region, thereby boosting the growth herein.
Elsewhere, the Asia Pacific market is expected to grow at a consistent pace. The region is reported to become a key market area for glaucoma surgeries in the coming years with the increasing prevalence of the disease and advancing healthcare technologies.  

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more